端粒酶在癌症早期检测中的应用
Telomerase in the early detection of cancer.
作者信息
Shay J W, Gazdar A F
机构信息
Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Centre at Dallas 75235-9039, USA.
出版信息
J Clin Pathol. 1997 Feb;50(2):106-9. doi: 10.1136/jcp.50.2.106.
Abstract
Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.
摘要
尽管对于端粒酶活性和癌症的早期检测存在合理的乐观态度，但必须指出的是，仍有许多有待了解的地方，在端粒酶活性知识可用于患者管理决策之前，还需要进行更多的验证研究。一个关键问题是，我们是否能够通过检测端粒酶活性来区分哪些癌症会进展，哪些不会。在这方面，使用端粒酶活性等标志物结合其他分子标志物进行分子分期可能特别有用。如果要使这一策略成熟，基础科学家和临床医生必须共同努力。人们对癌症治疗中端粒酶抑制剂的问世满怀期待。
相似文献
1
Telomerase in the early detection of cancer.端粒酶在癌症早期检测中的应用
J Clin Pathol. 1997 Feb;50(2):106-9. doi: 10.1136/jcp.50.2.106.
2
Telomerase: optimism for cancer marker grows.端粒酶：对癌症标志物的乐观情绪在增长。
Ann Oncol. 1995 Sep;6(7):624-30. doi: 10.1093/oxfordjournals.annonc.a059266.
3
Telomerase activity in cancer as a diagnostic and therapeutic target.癌症中的端粒酶活性作为一种诊断和治疗靶点。
Histol Histopathol. 2000 Jul;15(3):813-24. doi: 10.14670/HH-15.813.
4
Telomerase and early detection of cancer: a National Cancer Institute workshop.端粒酶与癌症早期检测：美国国立癌症研究所研讨会
J Natl Cancer Inst. 1997 May 7;89(9):618-23. doi: 10.1093/jnci/89.9.618.
5
[Detection of telomerase activity and its clinical application].[端粒酶活性的检测及其临床应用]
Rinsho Byori. 1997 Dec;45(12):1133-41.
6
Telomerase: a potential diagnostic and therapeutic tool in canine oncology.
Vet Pathol. 2003 Jan;40(1):1-7. doi: 10.1354/vp.40-1-1.
7
Real-time telomerase activity measurements for detection of cancer.用于癌症检测的端粒酶活性实时测量
Expert Rev Mol Diagn. 2005 Sep;5(5):745-53. doi: 10.1586/14737159.5.5.745.
8
Clinical utility of telomerase in cancer.端粒酶在癌症中的临床应用
Oncogene. 2002 Jan 21;21(4):643-9. doi: 10.1038/sj.onc.1205070.
9
Telomerase assays in the diagnosis and prognosis of cancer.端粒酶检测在癌症诊断和预后中的应用
Ciba Found Symp. 1997;211:148-55; discussion 155-9. doi: 10.1002/9780470515433.ch10.
10
Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.用于癌症早期检测的端粒酶活性分析验证：TRAP/PCR-CE及hTERT mRNA定量检测用于肿瘤细胞的高通量筛选
J Mol Diagn. 2004 Aug;6(3):157-65. doi: 10.1016/S1525-1578(10)60506-5.
引用本文的文献
1
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector Molecules.新大陆灵长类动物及其人类对应物共享富含癌胚抗原相关细胞黏附分子（CEACAM）和其他效应分子的疾病。
Life (Basel). 2025 Mar 17;15(3):481. doi: 10.3390/life15030481.
2
A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches.癌症与衰老中端粒损耗的综述：当前的分子见解及未来的治疗方法
Cancers (Basel). 2025 Jan 14;17(2):257. doi: 10.3390/cancers17020257.
3
Circulating TERT serves as the novel diagnostic and prognostic biomarker for the resectable NSCLC.循环中的端粒酶逆转录酶（TERT）可作为可切除非小细胞肺癌（NSCLC）的新型诊断和预后生物标志物。
Cancer Cell Int. 2024 Dec 19;24(1):420. doi: 10.1186/s12935-024-03605-w.
4
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.一项关于人端粒酶逆转录酶（hTERT）疫苗接种联合控制免疫抑制机制治疗策略的1期试验。
Exp Biol Med (Maywood). 2024 Jan 31;249:10021. doi: 10.3389/ebm.2024.10021. eCollection 2024.
5
RESISTIN EFFECT ON TELOMERASE GENE EXPRESSION IN GASTRIC CANCER CELL LINE AGS.抵抗素对胃癌细胞系AGS中端粒酶基因表达的影响
Acta Endocrinol (Buchar). 2016 Apr-Jun;12(2):145-149. doi: 10.4183/aeb.2016.145.
6
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.人类端粒酶逆转录酶 (hTERT) 调控机制：癌症中的临床影响。
J Biomed Sci. 2018 Mar 12;25(1):22. doi: 10.1186/s12929-018-0422-8.
7
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.乳腺癌中的微小残留病：循环肿瘤细胞和播散肿瘤细胞概述
Clin Exp Metastasis. 2016 Aug;33(6):521-50. doi: 10.1007/s10585-016-9796-8. Epub 2016 May 17.
8
Toward a molecular classification of colorectal cancer: the role of telomere length.迈向结直肠癌的分子分类：端粒长度的作用。
Front Oncol. 2014 Jun 18;4:158. doi: 10.3389/fonc.2014.00158. eCollection 2014.
9
Identification of new natural DNA G-quadruplex binders selected by a structure-based virtual screening approach.基于结构的虚拟筛选方法筛选到的新型天然 DNA G-四链体结合物的鉴定。
Molecules. 2013 Sep 30;18(10):12051-70. doi: 10.3390/molecules181012051.
10
What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.我们对马来西亚中枢神经系统（CNS）肿瘤分子遗传学的了解。
Malays J Med Sci. 2004 Jan;11(1):37-43.
本文引用的文献
1
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.人急性髓性白血病中的端粒酶活性：分化诱导剂对端粒酶活性的抑制作用。
Clin Cancer Res. 1996 May;2(5):799-803.
2
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.癌前及肿瘤性胃和结肠病变中的端粒酶活性
Clin Cancer Res. 1995 Nov;1(11):1245-51.
3
Refining the telomere-telomerase hypothesis of aging and cancer.完善衰老与癌症的端粒-端粒酶假说。
Nat Biotechnol. 1996 Jul;14(7):836-9. doi: 10.1038/nbt0796-836.
4
Inhibition of human telomerase activity by peptide nucleic acids.肽核酸对人端粒酶活性的抑制作用。
Nat Biotechnol. 1996 May;14(5):615-9. doi: 10.1038/nbt0596-615.
5
Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.成人骨髓造血祖细胞中端粒酶活性的差异表达。
Stem Cells. 1996 Mar;14(2):239-48. doi: 10.1002/stem.140239.
6
Telomerase activity in human germline and embryonic tissues and cells.人类生殖系及胚胎组织和细胞中的端粒酶活性。
Dev Genet. 1996;18(2):173-9. doi: 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3.
7
The reactivation of telomerase activity in cancer progression.端粒酶活性在癌症进展中的重新激活。
Trends Genet. 1996 Apr;12(4):129-31. doi: 10.1016/0168-9525(96)30018-8.
8
Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?
Trends Genet. 1996 Apr;12(4):127-8. doi: 10.1016/0168-9525(96)30016-4.
9
Telomerase activity in human cancer.人类癌症中的端粒酶活性
Curr Opin Oncol. 1996 Jan;8(1):66-71. doi: 10.1097/00001622-199601000-00012.
10
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.人类乳腺癌和乳腺良性病变中的端粒酶活性：在临床标本（包括细针穿刺抽吸物）中的诊断应用
Int J Cancer. 1996 Aug 22;69(4):301-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8.
Zotero 插件